Chugai Pharmaceutical Co., Ltd.
4519
Classement en actions
#356
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Prix de l'action
$40.97
Capitalisation boursière
$67.42B
Changement (1 jour)
-1.15%
Changement (1 an)
-15.68%
Pays
JP
Échange Chugai Pharmaceutical Co., Ltd. (4519)
Catégorie
Healthcare
Capitalisation boursière de Chugai Pharmaceutical Co., Ltd.(4519)
Capitalisation boursière: $67.42B
En October 2026, Chugai Pharmaceutical Co., Ltd. a une capitalisation boursière de $67.42B. Cela fait de Chugai Pharmaceutical Co., Ltd. la 356th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Chugai Pharmaceutical Co., Ltd. du 2000 au 2026
4519 par rapport au top 5 des plus populaires stocks
